172 related articles for article (PubMed ID: 18594527)
1. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
Attard G; Clark J; Ambroisine L; Mills IG; Fisher G; Flohr P; Reid A; Edwards S; Kovacs G; Berney D; Foster C; Massie CE; Fletcher A; De Bono JS; Scardino P; Cuzick J; Cooper CS;
Br J Cancer; 2008 Jul; 99(2):314-20. PubMed ID: 18594527
[TBL] [Abstract][Full Text] [Related]
2. Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.
Barros-Silva JD; Paulo P; Bakken AC; Cerveira N; Løvf M; Henrique R; Jerónimo C; Lothe RA; Skotheim RI; Teixeira MR
Neoplasia; 2013 Jul; 15(7):720-6. PubMed ID: 23814484
[TBL] [Abstract][Full Text] [Related]
3. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.
Reid AH; Attard G; Ambroisine L; Fisher G; Kovacs G; Brewer D; Clark J; Flohr P; Edwards S; Berney DM; Foster CS; Fletcher A; Gerald WL; Møller H; Reuter VE; Scardino PT; Cuzick J; de Bono JS; Cooper CS;
Br J Cancer; 2010 Feb; 102(4):678-84. PubMed ID: 20104229
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.
Gasi D; van der Korput HA; Douben HC; de Klein A; de Ridder CM; van Weerden WM; Trapman J
PLoS One; 2011 Jan; 6(1):e16332. PubMed ID: 21298110
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.
Winnes M; Lissbrant E; Damber JE; Stenman G
Oncol Rep; 2007 May; 17(5):1033-6. PubMed ID: 17390040
[TBL] [Abstract][Full Text] [Related]
8. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
9. Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer.
Kunju LP; Carskadon S; Siddiqui J; Tomlins SA; Chinnaiyan AM; Palanisamy N
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):e32-40. PubMed ID: 25203299
[TBL] [Abstract][Full Text] [Related]
10. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.
Hermans KG; van der Korput HA; van Marion R; van de Wijngaart DJ; Ziel-van der Made A; Dits NF; Boormans JL; van der Kwast TH; van Dekken H; Bangma CH; Korsten H; Kraaij R; Jenster G; Trapman J
Cancer Res; 2008 Sep; 68(18):7541-9. PubMed ID: 18794142
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
Higgins J; Brogley M; Palanisamy N; Mehra R; Ittmann MM; Li JZ; Tomlins SA; Robins DM
Horm Cancer; 2015 Jun; 6(2-3):67-86. PubMed ID: 25631336
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.
Rajput AB; Miller MA; De Luca A; Boyd N; Leung S; Hurtado-Coll A; Fazli L; Jones EC; Palmer JB; Gleave ME; Cox ME; Huntsman DG
J Clin Pathol; 2007 Nov; 60(11):1238-43. PubMed ID: 17259299
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.
Dong J; Xiao L; Sheng L; Xu J; Sun ZQ
Asian Pac J Cancer Prev; 2014; 15(7):3099-103. PubMed ID: 24815454
[TBL] [Abstract][Full Text] [Related]
14. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
[TBL] [Abstract][Full Text] [Related]
15. Testing mutual exclusivity of ETS rearranged prostate cancer.
Svensson MA; LaFargue CJ; MacDonald TY; Pflueger D; Kitabayashi N; Santa-Cruz AM; Garsha KE; Sathyanarayana UG; Riley JP; Yun CS; Nagy D; Kosmeder JW; Pestano GA; Tewari AK; Demichelis F; Rubin MA
Lab Invest; 2011 Mar; 91(3):404-12. PubMed ID: 20975660
[TBL] [Abstract][Full Text] [Related]
16. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
18. ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C; Hsieh CL; Omwancha J; Zheng Z; Chen SY; Baert JL; Shemshedini L
Mol Endocrinol; 2007 Aug; 21(8):1835-46. PubMed ID: 17505060
[TBL] [Abstract][Full Text] [Related]
19. Detection of TMPRSS2 gene deletions and translocations in carcinoma, intraepithelial neoplasia, and normal epithelium of the prostate by direct fluorescence in situ hybridization.
Zhang S; Pavlovitz B; Tull J; Wang Y; Deng FM; Fuller C
Diagn Mol Pathol; 2010 Sep; 19(3):151-6. PubMed ID: 20736744
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trial.
Palanisamy N; Tsodikov A; Yan W; Suleman K; Rittmaster R; Lucia SM; Chinnaiyan AM; Fleshner N; Kunju LP
Urol Oncol; 2015 Mar; 33(3):108.e5-13. PubMed ID: 25175425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
